Clinical outcome in stage I to III breast carcinoma and elF4E overexpression

Annals of Surgery

Volumn 227, Issue 5, 1998, Pages 756-763

  Li, Benjamin D L ^b,d   McDonald, John C ^b   Nassar, Raja ^c   De Benedetti, Arrigo ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c Louisiana Tech University   (United States)

^d LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; GENE PRODUCT; ORNITHINE DECARBOXYLASE;

ADULT; BREAST BIOPSY; BREAST CANCER; BREAST RECONSTRUCTION; CANCER RECURRENCE; CANCER STAGING; CONFERENCE PAPER; DENSITOMETRY; FEMALE; FOLLOW UP; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; SURGICAL MORTALITY; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; HUMANS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PEPTIDE INITIATION FACTORS; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0031795848     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199805000-00016     Document Type: Conference Paper

References (20)

1. Rhoads RE, Joshi-Barve S, Rinker-Schaeffer C. Mechanism of action and regulation of protein synthesis initiation factor 4E: effects of mRNA discrimination, cellular growth rate, and oncogenesis. Prog Nucleic Acid Res Mol Biol 1993; 46:183-219.
2. Sonenberg N. mRNA 5′ Cap-binding protein eIF4E and control of cell growth. In: Hershey JWB, Masters MB, Sonenberg N, eds. Translational Control. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1996:245-269.
3. Duncan R, Milburn SC, Hershey JB. Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF4E suggests a role in translational control. J Biol Chem 1987; 262:380-388.
4. De Benedetti A, Joshi-Barve S, Rinker-Schaeffer C, Rhoads RE. Expression of antisense RNA against initiation factor eIF4E mRNA in HeLa cells results in lengthened cell division times, diminished translation rates, and reduced levels of both eIF4E and p220 components of eIF4F. Mol Cell Biol 1991; 11(11):5435-5445.
5. Koromilas AE, Lazaris-Karatzas A, Sonenberg N. mRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor 4E. EMBO J 1992; 11:4153-4158.
6. Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV. Elevated levels of cyclin D1 in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 1993; 13(12):7358-7356.
7. Schantz LM, Coleman CS, Pegg AE. Overproduction of ornithine decarboxylase caused relief of translational repression is associated with neoplastic transformation. Cancer Res 1994; 54:2313-2316.
8. Kevil C, De Benedetti A, Payne DK, et al. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis. Int J Cancer 1996; 65(6):785-790.
9. Kevil CG, Carter P, Hu B, De Benedetti A. Translational enhancement of FGF-2 by eIF4E factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogene 1995; 11:2339-2348.
10. De Benedetti A, Rhoads RE. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc Natl Acad Scei, 1990; 87:8212-8216.
11. De Benedetti A, Joshi B, Graff JR, Zimmer SG. CHO cells transformed by the translation factor eIF-4E display increased c-myc expression, but require overexpression of max for tumorigenicity. Mol Cell Diff 1994; 2(4):347-371.
12. Rinker-Schaeffer CW, Graff JR, De Benedetti A. Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts. Int J Cancer 1993; 55:841-847.
13. Anthony B, Carter P, De Benedetti A. Overexpression of the proto-oncogene/translation factor 4E in breast carcinoma cell lines. Int J Cancer 1996; 65:858-863.
14. Kerekatte V, Smiley K, Hu B, et al. The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas. Int J Cancer 1995; 64(6):27-31.
15. Nathan CO, Liu L, Li BDL, et al. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer. Oncogene 1977; 15:579-584.
16. Li BDL, Liu L, Dawson M, De Benedetti A. Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma. Cancer 1997; 79(12):2385-2390.
17. Nathan CO, Carter P, Liu L, et al. Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas. Oncogene 1997; 15:1087-1094.
18. Weidner N, Semple J, Welch WR, et al. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
19. Feinstein A. The role of observational studies in the evaluation of therapy. Stat Med 1984; 3(4):341-345.
20. Byar DP. Why data bases should not replace randomized clinical trials. Biometrics 1980; 36:337.